NEW YORK (GenomeWeb News) — Swedish biotech company Genovis said today that Finnzymes will take over US logistical operations and handle some promotions for Genovis products in the US.
Genovis offers RNAi, transfection, imaging, and antibody engineering products to biotechnology companies and academic researchers. Finnzymes develops PCR, quantitative real-time PCR, transposon, and RNA technologies, and it offers PCR instruments, reaction vessels, and DNA polymerases.
Finnzymes President Mike Mortillaro said in a statement that Genovis has “a unique portfolio of products based upon highly advanced technologies, such as their proprietary nanoparticles for ultra-high efficiency transfection.”